Home › HIV › California › San Francisco
Pag-aaral pangklinika para sa HIV sa San Francisco, CA
Isang pag-aaral para sa HIV ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa San Francisco. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- Bridge HIV CRS, San Francisco
SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Nagre-recruitObservasyonal na pag-aaral
- San Francisco General Hospital, San Francisco
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Nagre-recruitPhase 3
- Optimus Medical Group, San Francisco
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Nagre-recruitPhase 2
- University of California, San Francisco, San Francisco
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Nagre-recruit
- University of California, San Francisco, San Francisco
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Nagre-recruitObservasyonal na pag-aaral
- University of California, San Francisco, San Francisco
Menopausal HT for Women Living With HIV (HoT)
Nagre-recruitPhase 4
- 801 University of California, San Francisco HIV/AIDS CRS, San Francisco
CAR-T Cells for HIV Infection
Nagre-recruitPhase 1/2
- Zuckerberg San Francisco General, San Francisco
SCOPE Analytic Treatment Interruption Protocol
Nagre-recruit
- University of California San Francisco, San Francisco
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Nagre-recruitPhase 2
- San Francisco General Hospital, San Francisco
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- Bridge HIV, San Francisco Department of Public Health, San Francisco
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
Nagre-recruitObservasyonal na pag-aaral
- University of California, San Francisco, San Francisco
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
Nagre-recruit
- Zuckerberg San Francisco General Hospital, San Francisco
- University of California San Francisco, San Francisco
Imaging Immune Activation in HIV by PET-MR
Nagre-recruitPhase 2
- University of California, San Francisco, San Francisco
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- San Francisco AIDS Foundation, San Francisco
Pag-aaral para sa HIV sa ibang lungsod
- Washington, DC22 pag-aaral
- New York City, NY19 pag-aaral
- Houston, TX17 pag-aaral
- Miami, FL17 pag-aaral
- Baltimore, MD16 pag-aaral
- Chicago, IL14 pag-aaral
- Atlanta, GA14 pag-aaral
- Philadelphia, PA11 pag-aaral
- Boston, MA11 pag-aaral
- San Diego, CA10 pag-aaral
- Los Angeles, CA9 pag-aaral
- Seattle, WA8 pag-aaral
Iba pang pag-aaral sa San Francisco
- Kanser sa Prostate45 pag-aaral
- Kanser sa Suso43 pag-aaral
- Non-Small Cell Lung Cancer36 pag-aaral
- Kanser (lahat ng uri)35 pag-aaral
- Pagkabigo ng Puso29 pag-aaral
- Metastatic Cancer28 pag-aaral
- Kanser sa Baga22 pag-aaral
- Melanoma22 pag-aaral
- Kanser sa Pancreas20 pag-aaral
- Kanser sa Ovary19 pag-aaral
- Colorectal Cancer18 pag-aaral
- Sakit sa Puso at Ugat ng Dugo18 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.